| scholarly article | Q13442814 |
| P50 | author | Claus Garbe | Q32649750 |
| P2093 | author name string | D Schadendorf | |
| A Hauschild | |||
| P Mohr | |||
| R Linse | |||
| S Ugurel | |||
| W Tilgen | |||
| T Vogt | |||
| U Trefzer | |||
| F Egberts | |||
| A Thoelke | |||
| M Kreissig | |||
| P433 | issue | 10 | |
| P921 | main subject | temozolomide | Q425088 |
| brain metastasis | Q1620196 | ||
| P304 | page(s) | 1592-1597 | |
| P577 | publication date | 2006-10-01 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study | |
| P478 | volume | 17 |
| Q35602183 | A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response |
| Q26770492 | Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition) |
| Q38548397 | Clinical Management of Multiple Melanoma Brain Metastases: A Systematic Review. |
| Q90711858 | Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients |
| Q38036217 | Combining stereotactic radiosurgery and systemic therapy for brain metastases: a potential role for temozolomide |
| Q38948151 | Current treatment options of brain metastases and outcomes in patients with malignant melanoma |
| Q37389096 | Dendritic cells in cancer immunotherapy clinical trials: are we making progress? |
| Q33386298 | Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. |
| Q26801928 | Malignant melanoma mimicking giant cell variant of glioblastoma multiforme: a case report and review of literature |
| Q35214698 | Melanoma brain metastases: is it time to reassess the bias? |
| Q37480713 | Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases |
| Q35967411 | Preclinical approaches to study the biology and treatment of brain metastases |
| Q61136651 | Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases |
| Q51742545 | Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study. |
| Q37576025 | Temozolomide for treatment of brain metastases: A review of 21 clinical trials |
| Q46367364 | Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study |
| Q39002330 | The Treatment of Melanoma Brain Metastases |
| Q37586262 | The role of chemotherapy in the treatment of patients with brain metastases from solid tumors |
| Q33599167 | The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics |
Search more.